stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Return on equity
Stevanato Group S.p.A.'s return on equity over the twelve months to 30 September 2026 was 9.22%, down 0.7 percentage points from fiscal 2025 (9.88%). Over the past ten years it has ranged from 9.28% (fiscal 2024) to 27.5% (fiscal 2020); the current reading is higher than 29% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 9.88% | 0.60 |
| FY2024 | 9.28% | (4.58) |
| FY2023 | 13.9% | (0.86) |
| FY2022 | 14.7% | (8.82) |
| FY2021 | 23.5% | (3.96) |
| FY2020 | 27.5% | 14.52 |
| FY2019 | 13.0% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NVST Envista Holdings Corporation compare | 20.5% |
| MMSI Merit Medical Systems, Inc. compare | 9.78% |
| STVN Stevanato Group S.p.A. | 9.22% |
| ATRC AtriCure, Inc. compare | 2.95% |
| ICUI ICU Medical, Inc. compare | 2.79% |
| WRBY Warby Parker Inc. compare | 1.93% |
| MMED MiniMed Group, Inc. compare | 0.00% |
| TFX Teleflex Incorporated compare | −28.9% |
| PLSE Pulse Biosciences, Inc compare | −60.7% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement